Does the better prognosis associated with p16+ H&N cancers relate only to patients who are treated with RT +/- chemo?  

Does the better prognosis associated with p16+ H&N cancers relate only to patients who are treated with RT +/- chemo? Or do they do better in the post-op setting as well?  

For example, would observation be reasonable in a p16+ 80 year old woman with a pT1 pN2a M0 tonsil cancer (post-op) where the 4.5 cm LN is the ONLY indication for post-op RT? (clear margins (albeit 2 mm deep margin at the tonsil), no PNI, no ECE, etc. Clearly, it would be nice to avoid RT in this otherwise healthy but elderly woman.



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution